Device Compliance Endokit_endo

Compliance Endokit

Payments companies reported to CMS as associated with Compliance Endokit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$14Kassociated payments (2023-2025)
400clinicians with associated payments
1company reporting

By year

2023 $4,545
2024 $5,332
2025 $3,681

Payments reported as associated with Compliance Endokit, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $8,565
Internal Medicine $668
Family $541
Nurse Anesthetist, Certified Registered $505
Acute Care (Nurse Practitioner) $342
Surgery $255

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Compliance Endokit

These are the largest totals companies reported as associated with Compliance Endokit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Bijo Kythaparampil John San Antonio, TX Gastroenterology (Internal Medicine) $183.38
Jan Prazak San Antonio, TX Gastroenterology (Internal Medicine) $183.37
Kevin Dasher San Antonio, TX Gastroenterology (Internal Medicine) $156.96
Ravi Ganeshappa San Antonio, TX Gastroenterology (Internal Medicine) $155.31
Theodore Paradowski Springfield, IL Gastroenterology (Internal Medicine) $149.55
Steven Rodriguez Roselle Park, NJ Gastroenterology (Internal Medicine) $148.53
Edward Lung New York, NY Gastroenterology (Internal Medicine) $148.53
Kevin Franklin San Antonio, TX Gastroenterology (Internal Medicine) $142.74
Amit Goyal San Antonio, TX Gastroenterology (Internal Medicine) $142.74
Christie Morrison San Antonio, TX Acute Care (Nurse Practitioner) $142.73

Prescribed Compliance Endokit?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.